Devchand M, Gwynne D I
Allelix Biopharmaceuticals Inc., Mississauga, Ontario, Canada.
J Biotechnol. 1991 Jan;17(1):3-9. doi: 10.1016/0168-1656(91)90022-n.
Filamentous fungi, in particular those of the genus Aspergillus have been well exploited for their ability to produce high levels of extracellular proteins in an inexpensive manner. Since many human proteins with the potential to be used therapeutically are secreted and require post-translational modification for biological activity, eukaryotic expression-secretion systems have been targeted for development. Recent developments in DNA-mediated transformation systems have allowed the utilization of Aspergillus as a host for the production of recombinant proteins. Several features such as well-characterized genetics and the availability of many mutants make Aspergillus nidulans the organism of choice for development of expression secretion systems. Recombinant strains contain integrated expression cassettes often in multiple copy, which are mitotically stable. In this review, we discuss the recent progress made in the use of Aspergillus as expression secretion hosts for the production of proteins of therapeutic significance.
丝状真菌,特别是曲霉属的那些真菌,因其能够以低成本方式产生高水平的细胞外蛋白质而得到了充分利用。由于许多具有治疗潜力的人类蛋白质是分泌型的,并且需要翻译后修饰才能具有生物活性,因此真核表达分泌系统已成为开发的目标。DNA介导的转化系统的最新进展使得曲霉能够用作生产重组蛋白的宿主。诸如遗传特征明确以及有许多突变体等几个特性,使得构巢曲霉成为开发表达分泌系统的首选生物。重组菌株通常含有多拷贝整合的表达盒,这些表达盒在有丝分裂过程中是稳定的。在这篇综述中,我们讨论了将曲霉用作表达分泌宿主以生产具有治疗意义的蛋白质方面的最新进展。